[Antifibrillation drugs in tachycardial arrythmia].
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000517:prevention & control; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D011926:Rauwolfia / Q000627:therapeutic use; D013034:Sparteine / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D013610:Tachycardia / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D007093:Imidazoles; D013565:Sympatholytics; D013034:Sparteine; D011802:Quinidine; D011342:Procainamide
Flimmerwidrige Pharmaka bei tachykarden Rhythmusstörungen.